ARTICLE | Company News
EndoBiologics International Corp., VaxGen deal
May 9, 2005 7:00 AM UTC
The companies partnered to research a vaccine against meningitis B. VXGN will fund proof-of-concept studies during the next 12 months and has an exclusive option to continue product development. If VX...